• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT XL VASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT XL VASCULAR STENT Back to Search Results
Catalog Number EX061703C
Device Problems Difficult or Delayed Positioning (1157); Device Operates Differently Than Expected (2913)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/02/2017
Event Type  Injury  
Manufacturer Narrative
The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specification prior to shipment.As part of all complaint investigations, an attempt was made to evaluate the subject device as well as the device usage.In this case, no sample or image was provided for evaluation.Therefore, the reported event could not be reproduced.Potential contributing factors to the reported event have been considered.Previous investigations of similar complaints were reviewed.The reported stent compression may have been caused by an irregular stent placement as a consequence of high deployment forces during stent deployment.Also an unintended movement of the delivery system or excessive compression of the outer catheter during deployment may result in an irregular stent placement.A difficult anatomy of the target vessel or the tracking path may be another contributing factor to the reported event.Insufficient flushing of the device or not performing a pre-dilation also may contribute to this type of event.In this case, it was reported that no pre-dilation was performed.On the basis of the information available and as no sample or image was provided, a definitive root cause for the reported event could not be determined.The ifu supplied with this device sufficiently describes the correct stent placement procedure.Also the ifu indicates that the device must be flushed with sterile saline and that pre-dilation of the lesion should be performed by using standard techniques.Furthermore, the ifu states: "if excessive force is felt during stent deployment, do not force the stent system.Remove the stent system as possible, and replace with a new unit." and "remove slack from the delivery system catheter held outside the patient." the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant was unable to provide any patient or further procedural details to bard.Although this product is not sold in the u.S., this event is being reported under regulation 21cfr part 803 as it involves a similar device to a pma approved device sold in the u.S.Under # p070014.
 
Event Description
It was reported that during a stent placement procedure for treatment of a distal sfa occlusion of 12 cm length via antegrade approach through the groin, the vascular stent was difficult to deploy by using the thumbwheel and foreshortened to 7 cm during deployment.As reported, no pre-dilation of the lesion had been performed.An additional stent of the same brand was used to cover the lesion completely.There was no reported patient injury.
 
Manufacturer Narrative
The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specification prior to shipment.The subject device was not returned for evaluation; therefore, the reported deployment difficulties could not be verified.On the basis of the evaluation of the images provided, the reported stent foreshortening could be confirmed.The images show a stent implanted in the distal sfa for treatment of an occlusion with the distal part of the stent was foreshortened post stent placement.As reported, the images show a second stent placed in overlapping technique proximal to the first stent.Post-dilation was performed.The blood flow through the vessel was restored.Potential contributing factors to the reported event have been considered.Previous investigations of similar complaints were reviewed.The reported stent compression may result from an irregular stent placement caused by high deployment force during stent deployment by using the thumbwheel.Also an unintended movement of the delivery system or excessive compression of the outer catheter during stent deployment may result in an irregular stent placement.A difficult anatomy of the target vessel or the tracking path may be another contributing factor to the reported event.Insufficient flushing of the device or not performing a pre-dilation also may contribute to this type of event.In this case, it was reported that no pre-dilation was performed.On the basis of the information available and the images provided, a definitive root cause for the reported event could not be determined.The ifu supplied with this device sufficiently describes the correct stent placement procedure.Also the ifu indicates that the device must be flushed with sterile saline and that pre-dilation of the lesion should be performed by using standard techniques.Furthermore, the ifu states: "if excessive force is felt during stent deployment, do not force the stent system.Remove the stent system as possible, and replace with a new unit." and "remove slack from the delivery system catheter held outside the patient." updated 'additional event information' due to receipt of images.
 
Event Description
It was reported that during a stent placement procedure for treatment of a distal sfa occlusion of 12 cm length via antegrade approach through the groin, the vascular stent was difficult to deploy by using the thumbweel and foreshortened to 7 cm during deployment.As reported, no pre-dilation of the lesion had been performed.An additional stent of the same brand was used to cover the lesion completely.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT XL VASCULAR STENT
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG -9681442
wachhausstrasse 6
karlsruhe 76227
GM   76227
Manufacturer Contact
daniela mueller
wachhausstr. 6
karlsruhe 76227
GM   76227
0497219445
MDR Report Key6293754
MDR Text Key66277787
Report Number9681442-2017-00042
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeNL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2018
Device Catalogue NumberEX061703C
Device Lot NumberANAR0317
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/03/2017
Initial Date FDA Received02/01/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/13/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/18/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age84 YR
-
-